Table 1 Baseline sociodemographic and clinical characteristics of the total sample (n=273)
Women [n (%)] | 160 (58.2) |
Age [mean (SD)] (years) | 44.1 (7.9) |
Smoking [n (%)] | 76 (27.8) |
Heavy alcohol consumption [n (%)] | 39 (14.3) |
Blood pressure [mean (SD)] (mmHg) | |
Systolic | 142.7 (15.3) |
Diastolic | 89.3 (9.6) |
Obesity [n (%)] (BMI ≥ 30 kg/m2) | 168 (61.5) |
Dyslipidemia [n (%)] | 127 (46.5) |
Patients with antihypertensive treatment [n (%)] | 173 (63.3) |
Diuretics | 80 (29.1) |
Beta blockers | 54 (19.6) |
Angiotensin-converting-enzyme inhibitors | 54 (19.6) |
Calcium channel antagonists | 46 (16.7) |
Baseline electrocardiographic ST-T changes and left ventricular hypertrophy* [n (%)]: | |
Major ST (MC 9–2; 4–1; 4–2) | 15 (5.5) |
Inverse Major T wave (MC 5–1; 5–2) | 6 (2.2) |
Inverse Minor T wave (MC 5–3) | 16 (5.9) |
Minor ST (MC 4–3) | 5 (1.8) |
Left ventricular hypertrophy (Cornell criteria) | 24 (8.7) |